Drew Deniger - Sep 15, 2022 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
VP, Research and Development
Signature
/s/ Melinda Lackey, Attorney-in-Fact
Stock symbol
TCRT
Transactions as of
Sep 15, 2022
Transactions value $
$0
Form type
4
Date filed
9/19/2022, 04:30 PM
Previous filing
Apr 8, 2022
Next filing
Mar 17, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRT Employee Stock Option (right to buy) Award $0 +305K $0.00 305K Sep 15, 2022 Common Stock 305K $2.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest in a series of sixteen equal quarterly installments measured from September 15, 2022, with the first vesting occurring on December 15, 2022, subject to the Reporting Person's continuous service through each such date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney